Insulin Pens, Syringes, Pumps And Injectors Global Market Report 2024

Description

“Insulin Pens, Syringes, Pumps And Injectors Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on insulin pens, syringes, pumps and injectors market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for insulin pens, syringes, pumps and injectors? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The insulin pens, syringes, pumps and injectors market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

1) By Type: Pens; Injectors And Pumps; Syringes
2) By Pens: Reusable; Disposable
3) By Pumps: Tubed Pumps; Tubeless Pumps
4) By End Users: Hospitals; Homecare; Other End Users
Companies Mentioned: Novo Nordisk A/S; Eli Lilly and Company; Medtronic plc; Abbott Laboratories; Insulet Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Insulin pens, syringes, pumps, and injectors play a crucial role in regulating the blood glucose levels of diabetic individuals. These tools can be either reusable or disposable and are employed for the purpose of delivering the required insulin dosage into the bloodstream of diabetic patients.

The primary categories of insulin delivery devices and equipment encompass pens, injectors, pumps, and syringes. A syringe serves as an instrument for introducing or extracting fluids. Both reusable and disposable pens are utilized for insulin administration. Pumps are available in two forms, including tube pumps and tubeless pumps. These devices find applications in a variety of settings, such as hospitals, home care, and others.

The insulin pens, syringes, pumps, and injectors devices and equipment market research report is one of a series of new reports from The Business Research Company that provides insulin pens, syringes, pumps, and injectors devices and equipment market statistics, including insulin pens, syringes, pumps, and injectors devices and equipment industry global market size, regional shares, competitors with an insulin pens, syringes, pumps, and injectors devices and equipment market share, detailed insulin pens, syringes, pumps, and injectors devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the insulin pens, syringes, pumps, and injectors devices and equipment industry. This insulin pens, syringes, pumps, and injectors devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The insulin pens, syringes, pumps and injectors market size has grown strongly in recent years. It will grow from $23.3 billion in 2023 to $25.36 billion in 2024 at a compound annual growth rate (CAGR) of 8.8%. The increase during the historical period can be attributed to the following factors such as the escalating prevalence of diabetes, advancements in insulin delivery methods, the preference of patients for convenience, and the aging population.

The insulin pens, syringes, pumps and injectors market size is expected to see strong growth in the next few years. It will grow to $34.41 billion in 2028 at a compound annual growth rate (CAGR) of 7.9%. The expansion anticipated in the forecast period can be ascribed to several key factors, including the growth of emerging markets, regulatory support and reimbursement initiatives, the adoption of personalized medicine, and the increasing emphasis on value-based healthcare. Notable trends expected in the forecast period encompass the integration of artificial intelligence (AI), the emergence of handheld and wireless ultrasound devices, the utilization of 3D/4D imaging, and the adoption of fusion imaging techniques.

The global increase in diabetes prevalence is fueling the growth of the insulin pens, syringes, pumps, and injectors market. Factors such as the rising number of people affected by obesity, unhealthy dietary habits, lack of physical activity, and a growing elderly population are contributing to the worldwide surge in diabetes cases. In 2020, the US Centers for Disease Control and Prevention (CDC) reported that approximately 34.2 million Americans had diabetes. Moreover, the International Diabetes Federation estimated that in 2021, about 537 million adults were living with diabetes globally, with projections indicating this number would reach 783 million by 2045. Consequently, the increasing global prevalence of diabetes is a key driver for the insulin delivery device market's growth.

The expanding elderly population is expected to be a significant driver for the insulin pens, syringes, pumps, and injectors market in the future. The geriatric population consists of older individuals, typically aged 65 and above. The rising incidence of diabetes among this age group has created a demand for specialized insulin delivery solutions that enhance adherence, reduce complications, and improve the overall quality of life for older adults with diabetes. For instance, a report from the World Health Organization (WHO) in October 2022 highlighted that by 2030, one in six people worldwide is expected to be 60 or older, and by 2050, there will be 2.1 billion people aged 60 and above. The number of individuals aged 80 or older is projected to increase by 426 million between 2020 and 2050 compared to the current population. Therefore, the growing elderly population is a significant factor driving the insulin pens, syringes, pumps, and injectors market's growth.

Patient resistance to self-injection is a constraint on the insulin delivery device market. Many patients experience anxiety and fear related to injections, leading them to avoid insulin injections and be inconsistent in their insulin treatment. According to the National Center for Biotechnology Information (NCBI), approximately 30% to 50% of patients experience anxiety and fear associated with injection-related pain before receiving diabetes education interventions. The report also indicates that close to 28% of patients are unwilling to start insulin therapy due to a lack of confidence in managing injections and fear of needle pain during self-injection. This resistance to self-injection due to needle fear is impeding market growth.

Numerous companies are prioritizing technological advancements in insulin delivery systems to ensure effective and safe insulin delivery. For example, in September 2022, the FDA granted approval for the use of Omnipod 5 for children over the age of 2 with type 1 diabetes. Omnipod is the first tubeless automated insulin delivery system for individuals with type 1 diabetes.

Strategic partnerships are a prominent trend in the insulin pens, syringes, pumps, and injectors market. Major companies in this sector offer a wide range of products and technologies to cater to the needs of individuals with diabetes. In December 2022, Eli Lilly and Company, a US-based pharmaceutical firm, joined forces with Eva Pharma, an Egypt-based pharmaceutical company, with the aim of enhancing sustainable access to affordable insulin in low- and middle-income countries, particularly in Africa, making insulin more accessible and affordable to those in need.

In September 2023, Abbott Laboratories, a US-based medical device company, completed the acquisition of Bigfoot Biomedical Inc. for an undisclosed sum. This acquisition is part of Abbott's strategy to expand its presence in diabetes care and strengthen its portfolio of connected diabetes solutions. Bigfoot Biomedical Inc. is a US medical technology company specializing in the development and manufacturing of diabetes management systems, including insulin pens and syringes.

Major companies operating in the insulin pens, syringes, pumps and injectors market include Novo Nordisk A/S, Eli Lilly and Company, Medtronic PLC, Abbott Laboratories, Insulet Corporation, Sanofi Aventis, F. Hoffmann-La Roche Ltd., Becton Dickinson and Company, Animas Corporation, Ypsomed Holding AG, Dickinson and Company, Valeritas Inc., MannKind Corporation, Tandem Diabetes Care Inc., Biocon Ltd., B. Braun Melsungen AG, Terumo Corporation, Teleflex Incorporated, Nipro Corporation, Smiths Medical Inc., Owen Mumford, UltiMed Inc., Ypsomed Holding, Ascensia Diabetes Care, Trividia Health, ARKRAY Inc., AgaMatrix Inc., Medline Industries LP, Gerresheimer AG, West Pharmaceutical Services Inc., SHL Medical AG, Zhejiang POCTech Medical Co.Ltd., Jiangsu Wanhai Medical Instruments Co. Ltd.

North America was the largest region in the global insulin pens, syringes, pumps, and injectors devices and equipment market in 2023. Asia-Pacific was the second-largest region in insulin pens, syringes, pumps, and injectors devices and equipment market. The regions covered in the insulin pens, syringes, pumps and injectors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the insulin pens, syringes, pumps and injectors market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The insulin pens, syringes, pumps, and injectors market consist of sales of reusable pens, disposable pens, tubed pumps, and tubeless pumps that are used for injecting insulin. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Product Code: r8963

1. Executive Summary

2. Insulin Pens, Syringes, Pumps And Injectors Market Characteristics

3. Insulin Pens, Syringes, Pumps And Injectors Market Trends And Strategies

4. Insulin Pens, Syringes, Pumps And Injectors Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Insulin Pens, Syringes, Pumps And Injectors Market Size and Growth

5.1. Global Insulin Pens, Syringes, Pumps And Injectors Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Insulin Pens, Syringes, Pumps And Injectors Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Insulin Pens, Syringes, Pumps And Injectors Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Insulin Pens, Syringes, Pumps And Injectors Market Segmentation

6.1. Global Insulin Pens, Syringes, Pumps And Injectors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Pens
Injectors And Pumps
Syringes
6.2. Global Insulin Pens, Syringes, Pumps And Injectors Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals
Homecare
Other End Users

7. Insulin Pens, Syringes, Pumps And Injectors Market Regional And Country Analysis

7.1. Global Insulin Pens, Syringes, Pumps And Injectors Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Insulin Pens, Syringes, Pumps And Injectors Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Insulin Pens, Syringes, Pumps And Injectors Market

8.1. Asia-Pacific Insulin Pens, Syringes, Pumps And Injectors Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Insulin Pens, Syringes, Pumps And Injectors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Insulin Pens, Syringes, Pumps And Injectors Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Insulin Pens, Syringes, Pumps And Injectors Market

9.1. China Insulin Pens, Syringes, Pumps And Injectors Market Overview
9.2. China Insulin Pens, Syringes, Pumps And Injectors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Insulin Pens, Syringes, Pumps And Injectors Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Insulin Pens, Syringes, Pumps And Injectors Market

10.1. India Insulin Pens, Syringes, Pumps And Injectors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Insulin Pens, Syringes, Pumps And Injectors Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Insulin Pens, Syringes, Pumps And Injectors Market

11.1. Japan Insulin Pens, Syringes, Pumps And Injectors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.2. Japan Insulin Pens, Syringes, Pumps And Injectors Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Insulin Pens, Syringes, Pumps And Injectors Market

12.1. Australia Insulin Pens, Syringes, Pumps And Injectors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Insulin Pens, Syringes, Pumps And Injectors Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Insulin Pens, Syringes, Pumps And Injectors Market

13.1. Indonesia Insulin Pens, Syringes, Pumps And Injectors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Insulin Pens, Syringes, Pumps And Injectors Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Insulin Pens, Syringes, Pumps And Injectors Market

14.1. South Korea Insulin Pens, Syringes, Pumps And Injectors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.2. South Korea Insulin Pens, Syringes, Pumps And Injectors Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Insulin Pens, Syringes, Pumps And Injectors Market

15.1. Western Europe Insulin Pens, Syringes, Pumps And Injectors Market Overview
15.2. Western Europe Insulin Pens, Syringes, Pumps And Injectors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Insulin Pens, Syringes, Pumps And Injectors Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Insulin Pens, Syringes, Pumps And Injectors Market

16.1. UK Insulin Pens, Syringes, Pumps And Injectors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Insulin Pens, Syringes, Pumps And Injectors Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Insulin Pens, Syringes, Pumps And Injectors Market

17.1. Germany Insulin Pens, Syringes, Pumps And Injectors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Insulin Pens, Syringes, Pumps And Injectors Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Insulin Pens, Syringes, Pumps And Injectors Market

18.4. France Insulin Pens, Syringes, Pumps And Injectors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.5. France Insulin Pens, Syringes, Pumps And Injectors Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Insulin Pens, Syringes, Pumps And Injectors Market

19.7. Italy Insulin Pens, Syringes, Pumps And Injectors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.8. Italy Insulin Pens, Syringes, Pumps And Injectors Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Insulin Pens, Syringes, Pumps And Injectors Market

20.10. Spain Insulin Pens, Syringes, Pumps And Injectors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.11. Spain Insulin Pens, Syringes, Pumps And Injectors Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Insulin Pens, Syringes, Pumps And Injectors Market

21.1. Eastern Europe Insulin Pens, Syringes, Pumps And Injectors Market Overview
21.2. Eastern Europe Insulin Pens, Syringes, Pumps And Injectors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Insulin Pens, Syringes, Pumps And Injectors Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Insulin Pens, Syringes, Pumps And Injectors Market

22.1. Russia Insulin Pens, Syringes, Pumps And Injectors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Insulin Pens, Syringes, Pumps And Injectors Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Insulin Pens, Syringes, Pumps And Injectors Market

23.1. North America Insulin Pens, Syringes, Pumps And Injectors Market Overview
23.2. North America Insulin Pens, Syringes, Pumps And Injectors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Insulin Pens, Syringes, Pumps And Injectors Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Insulin Pens, Syringes, Pumps And Injectors Market

24.1. USA Insulin Pens, Syringes, Pumps And Injectors Market Overview
24.2. USA Insulin Pens, Syringes, Pumps And Injectors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Insulin Pens, Syringes, Pumps And Injectors Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Insulin Pens, Syringes, Pumps And Injectors Market

25.1. Canada Insulin Pens, Syringes, Pumps And Injectors Market Overview
25.2. Canada Insulin Pens, Syringes, Pumps And Injectors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Insulin Pens, Syringes, Pumps And Injectors Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Insulin Pens, Syringes, Pumps And Injectors Market

26.1. South America Insulin Pens, Syringes, Pumps And Injectors Market Overview
26.2. South America Insulin Pens, Syringes, Pumps And Injectors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Insulin Pens, Syringes, Pumps And Injectors Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Insulin Pens, Syringes, Pumps And Injectors Market

27.1. Brazil Insulin Pens, Syringes, Pumps And Injectors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Insulin Pens, Syringes, Pumps And Injectors Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Insulin Pens, Syringes, Pumps And Injectors Market

28.1. Middle East Insulin Pens, Syringes, Pumps And Injectors Market Overview
28.2. Middle East Insulin Pens, Syringes, Pumps And Injectors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Insulin Pens, Syringes, Pumps And Injectors Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Insulin Pens, Syringes, Pumps And Injectors Market

29.1. Africa Insulin Pens, Syringes, Pumps And Injectors Market Overview
29.2. Africa Insulin Pens, Syringes, Pumps And Injectors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Insulin Pens, Syringes, Pumps And Injectors Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Insulin Pens, Syringes, Pumps And Injectors Market Competitive Landscape And Company Profiles

30.1. Insulin Pens, Syringes, Pumps And Injectors Market Competitive Landscape
30.2. Insulin Pens, Syringes, Pumps And Injectors Market Company Profiles
- 30.2.1. Novo Nordisk A/S
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Eli Lilly and Company
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Medtronic plc.
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Abbott Laboratories
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Insulet Corporation
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Global Insulin Pens, Syringes, Pumps And Injectors Market Competitive Benchmarking

32. Global Insulin Pens, Syringes, Pumps And Injectors Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Insulin Pens, Syringes, Pumps And Injectors Market

34. Insulin Pens, Syringes, Pumps And Injectors Market Future Outlook and Potential Analysis

34.1 Insulin Pens, Syringes, Pumps And Injectors Market In 2028 - Countries Offering Most New Opportunities
34.2 Insulin Pens, Syringes, Pumps And Injectors Market In 2028 - Segments Offering Most New Opportunities
34.3 Insulin Pens, Syringes, Pumps And Injectors Market In 2028 - Growth Strategies
34.3.1 Market Trend Based Strategies
34.3.2 Competitor Strategies

35. Appendix

35.1. Abbreviations
35.2. Currencies
35.3. Historic And Forecast Inflation Rates
35.4. Research Inquiries
35.5. The Business Research Company
35.6. Copyright And Disclaimer